-+undefined NaN%
-+undefined NaN%
-+undefined NaN%

SVB Leerink Maintains Market Perform on bluebird bio, Raises Price Target to $9

Benzinga · 01/06/2023 12:11
SVB Leerink analyst Mani Foroohar maintains bluebird bio (NASDAQ:BLUE) with a Market Perform and raises the price target from $8 to $9.